Pharmacogenetics and Pharmacogenomics in Personalized Medicine

Dear Colleagues,

Pharmacogenomics has made numerous contributions to understanding the variability and explaining the uncertainty of drug responses, and is recognized as a cornerstone of personalized medicine in the future. For the successful establishment of personalized medicine, it is very important to discover genetic and clinical factors that affect drug responses and to share them in a Special Issue of the Journal of Personalized Medicine.

The aim and scope of the Special Issue is to discover and present genetic variants, biomarkers, and research tools that can be helpful in understanding drug side effects, drug resistance, and human susceptibility to diseases.

Cutting-edge research in pharmacogenomics could be described in two stages. First, it involves studying “the interaction network” after integrating various information obtained from functional genomics, proteomics, transcriptomics, metabolomics, and medical informatics. Second, the cutting-edge research in pharmacogenomics is focused on creating a standard guideline that can be personalized and applied to humans by verifying the research results obtained through integrated network analysis in prospective clinical trials.

Suitable topics for this Special Issue include, but are not limited to: pharmacogenomics with human diseases or drugs, such as cardiovascular diseases; psychiatry diseases; gastrointestinal diseases; cancers; drug addictions; drug sensitivities; drug resistances; and a broad range of adverse drug reactions. In addition, authors are encouraged to present novel pharmacogenetic assays, methodologies, tools, modellings, and functional data. We welcome original research papers, reviews, and updated overviews in pharmacogenetics and pharmacogenomics.

Dr. Su-Jun Lee
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.